Laenkholm AV, Jensen MB, Eriksen JO, Roslind A, et al. Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer. Clin Breast Cancer 2020 Feb 4. pii: S1526-8209(20)30029.
PMID: 32253134